Krka-Polskasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-06
Share capital
17,490,000.00 PLN
Registered address
Równoległa 5, 02-235 Warszawa, Poland
Electronic delivery address
AE:PL-69979-17348-IWHEF-34

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 42 days early. All were audited by a statutory auditor.

  • 202515/06/2026
  • 202406/06/2025
  • 202317/06/2024
  • 202215/06/2023
  • 202120/06/2022
  • 202005/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 88.35mMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 4.61mMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 82.25mMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 57.67mMedianUSD 883.09kAverageUSD 31.39m

Industry

Trademarks

Krka-Polska currently holds no active trademarks with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2006.

MarkNumberClassesStatusProtected until
Septolete. I z gardłem lepiej.(word)Z.3474305Refused –
Dermabion. Któż nie chciałby być w mojej skórze?(word)Z.3316915Proceedings discontinued –
Septolete. I z gardłem lepiej.(word)Z.3316925Proceedings discontinued –
Czy Twoja praca wymaga intensywnego myślenia? Bilobil forte na intensywne myślenie(word)Z.3159565Proceedings discontinued –
Łagodzi bóle stawów i mięśni(word)Z.3148335Refused –
MarkProtected until
Septolete. I z gardłem lepiej.(word)–
Dermabion. Któż nie chciałby być w mojej skórze?(word)–
Septolete. I z gardłem lepiej.(word)–
Czy Twoja praca wymaga intensywnego myślenia? Bilobil forte na intensywne myślenie(word)–
Łagodzi bóle stawów i mięśni(word)–

Authorized Representatives

Tomaž Indihar – President of the Management Board
Klaudia Wnuk – Management Board Member

Manner of representation

If one member of the management board has been appointed, that person is entitled to represent the company independently. If a multi-member management board has been appointed, the President of the Management Board independently and each member of the management board independently are authorised to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Krka, D.d., Novo Mesto
349,800$4,724,473.26100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1996-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$257.3K
Buildings and premises
$4M

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,974
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,737

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Name
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.
Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.
VercoS.A.
MedicofarmaS.A.
VitamaS.A.
Munar PharmaS.A.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.
Auxilius PharmaS.A.
Stg25Branch (foreign co.)

FAQ

Last updated: 2026-10-07